Optimum investments in project evaluations: when are cost-effectiveness analyses cost-effective?

Area of Science:

• Health economics
• Decision analysis
• Medical informatics

Background:

• Classical value of information models guide research investment decisions.
• Cost-effectiveness analysis (CEA) is a common tool for evaluating healthcare interventions.
• Retrospective data analysis, watchful waiting, and randomized clinical trials (RCTs) are distinct methodologies for assessing healthcare options.

Purpose of the Study:

• To determine if a hospital's net financial return can be maximized using cost-effectiveness analysis of retrospective data.
• To compare the financial implications of retrospective data analysis against watchful waiting and full randomized clinical trials.
• To explore the influence of risk aversion on the value of information and optimal project expenditure.

Main Methods:

• Extension of classical value of information models.
• Comparative analysis of financial returns from different data methodologies (retrospective vs. RCTs).
• Inclusion of watchful waiting as a baseline or alternative strategy.

Main Results:

• Small-scale retrospective analyses may lead to a negative net financial return for hospitals.
• Larger-scale retrospective analyses can, under certain conditions, maximize a hospital's net income.
• Increased risk aversion correlates with a higher value of information and optimal expenditure on project evaluation.

Conclusions:

• The optimal methodology for evaluating healthcare interventions depends on scale and specific conditions.
• Retrospective data analysis can be financially beneficial, particularly at larger scales.
• Risk-averse decision-making enhances the perceived value of further information, influencing investment in project evaluation.